Your session is about to expire
← Back to Search
Behavioural Intervention
Knee Kinesiography for Anterior Knee Pain
N/A
Recruiting
Led By Don L Goss, DPT, PhD
Research Sponsored by Womack Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18-50
Diagnosis of patellofemoral pain (ICD-10 codes: M25.2, M25.561, and M25.562)
Must not have
History of traumatic knee injury, such as a ligament tear or meniscal tear
Presence of rheumatoid or neurological disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if using information from the Emovi Knee Kinesiography can help treat anterior knee pain in physical therapy.
Who is the study for?
This trial is for active duty service members aged 18-50 stationed at Fort Liberty and Schofield Barracks, diagnosed with patellofemoral pain. It's not open to those with a history of traumatic knee injury, rheumatoid or neurological diseases, previous knee surgery, other lower limb injuries, individuals moving from the station within three months, or pregnant women.
What is being tested?
The study tests if using Emovi Knee Kinesiography—a device that assesses knee movement—helps in treating anterior knee pain during physical therapy. Participants are randomly chosen to either receive this new assessment tool or continue with standard care.
What are the potential side effects?
Since the intervention involves non-invasive kinesiography there may be minimal side effects related directly to its use; however, potential discomfort from positioning during assessment could occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 50 years old.
Select...
I have been diagnosed with knee pain.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had a serious knee injury, like a torn ligament or meniscus.
Select...
I have rheumatoid arthritis or a neurological condition.
Select...
I have had knee surgery in the past.
Select...
I have a current injury to my lower limb, like an ankle sprain.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function
Secondary study objectives
Anterior Knee Pain Scale (AKPS)
Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference
Provider Satisfaction
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention: Knee KG informed physical therapyExperimental Treatment1 Intervention
Participants in this group will receive care guided by the impairments identified with the KneeKG. The KneeKG exam results in recommended exercises that target the specific biomechanical impairments identified. The exercises and dose given to the participant will be based on what the KneeKG device recommends after the exam. The participant will be seen twice a week for 4 weeks.
Group II: Control: Standard of care physical therapyActive Control1 Intervention
Participants in this arm will have their KneeKG data captured, but this information will not be provided to the physical therapist to inform their care. Instead, physical therapists will deliver care as they normally do in routine clinical practice. The participant will be seen twice a week for 4 weeks.
Find a Location
Who is running the clinical trial?
Womack Army Medical CenterLead Sponsor
21 Previous Clinical Trials
16,915 Total Patients Enrolled
Medical Technology Enterprise ConsortiumUNKNOWN
2 Previous Clinical Trials
160 Total Patients Enrolled
The Geneva FoundationOTHER
37 Previous Clinical Trials
13,471 Total Patients Enrolled
Don L Goss, DPT, PhDPrincipal InvestigatorWomack Army Medical Center